季线金叉,月线KDJ已掉头向上,大底部持续放量,从历史最低点仅上涨一倍,待利好消息逐步释放,20倍以上目标可待。查看全文
利弗魔尔2021-03-12 02:04
$Invivo治疗控股(NVIV)$ 神经脊髓支架,这个有科技含量啊,异动,估计很快有更大动作,4000万市值,目标3倍。$苹果(AAPL)$ $特斯拉(TSLA)$查看全文
chuminhua2021-03-03 16:37
3月2日,Inovio Pharmaceuticals宣布,其基于DNA的在研HPV免疫疗法VGX-3100在一项后期试验中达到了可评估受试者的主要和次要终点,可作为与人乳头瘤病毒(HPV)相关的高级别鳞状上皮内病变(HSIL)的潜在疗法。首席执行官J.Joseph Kim提出,如果获得批准,VGX-3100有可能 "成为受HPV-16-/18相...查看全文
$Invivo治疗控股(NVIV)$ PRE 14A - Other preliminary proxy statements Filed: 2019-04-15 AccNo: 0001558370-19-003007 Size: 1 MB 网页链接
$Invivo治疗控股(NVIV)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2019-04-01 AccNo: 0001558370-19-002671 Size: 8 MB 网页链接
$Invivo治疗控股(NVIV)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2019-04-01 AccNo: 0001558370-19-002673 Size: 191 KB 网页链接
$Invivo治疗控股(NVIV)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2019-02-14 AccNo: 0001104659-19-008600 Size: 88 KB 网页链接
$Invivo治疗控股(NVIV)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2019-02-14 AccNo: 0001193125-19-040169 Size: 125 KB 网页链接
$Invivo治疗控股(NVIV)$ 8-K - Current report Filed: 2019-01-14 AccNo: 0001558370-19-000142 Size: 256 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 9.01: Financi...
$Invivo治疗控股(NVIV)$ 424B3 - Prospectus [Rule 424(b)(3)] Filed: 2019-01-14 AccNo: 0001558370-19-000145 Size: 262 KB 网页链接
$Invivo治疗控股(NVIV)$ 424B3 - Prospectus [Rule 424(b)(3)] Filed: 2019-01-14 AccNo: 0001558370-19-000147 Size: 266 KB 网页链接
$Invivo治疗控股(NVIV)$ 424B3 - Prospectus [Rule 424(b)(3)] Filed: 2019-01-14 AccNo: 0001558370-19-000148 Size: 266 KB 网页链接
$Invivo治疗控股(NVIV)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2019-01-04 AccNo: 0001535610-19-000037 Size: 13 KB 网页链接